Skip to main content
CadNews - Comparative News Analysis
Topics
Sign in
Back to brief

Sports · October 20, 2026

Jalen Hurts blood clots: Biggest unanswered questions for Eagles about star QB's health

7 sources →

Philadelphia Eagles quarterback Jalen Hurts is expected to miss the remainder of the 2026 season following a diagnosis of deep vein thrombosis (DVT) and bilateral pulmonary emboli. The condition originated from a calf injury sustained in Week 4 against the Los Angeles Rams, which initially presented as a superficial blood clot. Despite the diagnosis, Hurts played in a Week 5 game in London against the Jacksonville Jaguars after being cleared by team doctors, reportedly playing on limited rest following hospital evaluation. The team announced on October 19, 2026, that further testing revealed the clots had traveled to his lungs, requiring treatment with blood thinners that precludes contact sports. Head coach Nick Sirianni has defended the team's medical management of the situation.

Read the original coverage

Reported by multiple outlets

  • Jalen Hurts is expected to miss the rest of the 2026 NFL season.
  • The diagnosis includes deep vein thrombosis in the leg and bilateral pulmonary emboli in the lungs.
  • Hurts is being treated with blood thinners, which prevent him from participating in football activities.
  • The injury originated from a cleat to the calf in a Week 4 game against the Los Angeles Rams.
  • Hurts played in the Week 5 game against the Jacksonville Jaguars in London before the condition worsened.
  • The team's medical staff initially diagnosed the condition as superficial vein thrombosis.

Reported by only some outlets

  • Hurts spent time in a London hospital until early Sunday morning before the Week 5 game.
  • Tanner McKee has taken over as the Eagles' starting quarterback.
  • Hurts is 28 years old and a former Super Bowl MVP.
  • The team states Hurts has no significant functional limitations currently.

About these outlets

CadNews does not determine absolute truth or endorse political viewpoints. It compares publicly available reporting, identifies shared facts, highlights framing differences, and flags uncertainty.